Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

31.80
BATS BZX Real-Time Price
As of 11:05am ET
 +0.16 / +0.51%
Today’s Change
19.59
Today|||52-Week Range
65.34
-48.65%
Year-to-Date
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Ionis (IONS) Q2 Loss Narrower than Expected, Issues Outlook
Aug 10 / Zacks.com - Paid Partner Content
Ionis Pharmaceuticals Inc Begins to Shift Focus
Aug 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close31.64
Today’s open31.72
Day’s range31.13 - 32.04
Volume47,257
Average volume (3 months)2,641,775
Market cap$3.8B
Dividend yield--
Data as of 11:05am ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-44.49%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book18.96

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+1.22+3.76%
PTHNPatheon NV-0.14-0.50%
ICPTIntercept Pharmaceut...+4.87+3.07%
AKRXAkorn Inc-0.13-0.47%
Data as of 11:06am ET, 08/25/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.09
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts

Partner Offers

Search for Jobs